<DOC>
	<DOCNO>NCT01884337</DOCNO>
	<brief_summary>The primary purpose protocol evaluate safety Apixaban prophylaxis Venous Thromboembolism ( VTE ) Indian patient undergo elective total knee hip replacement</brief_summary>
	<brief_title>Multi-center Study Evaluate Safety Apixaban ( BMS-562247 ) Indian Subjects Undergoing Elective Total Knee Replacement Total Hip Replacement Surgery</brief_title>
	<detailed_description />
	<mesh_term>Apixaban</mesh_term>
	<criteria>Age â‰¥18 year Subjects undergo elective total knee hip replacement revision least one component total knee hip replacement Women pregnant breastfeed Known suspect , acquire bleed coagulation disorder subject first degree relative Active bleeding high risk bleeding . Brain , spinal , ophthalmologic , major surgery trauma within past 90 day elective knee/hip surgery Active hepatobiliary disease Hemoglobin &lt; 9 g/dL Platelet count &lt; 100,000/mm3 Creatinine clearance &lt; 30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>